Literature DB >> 508511

Blood pressure reduction by incremental infusion of labetalol in patients with severe hypertension.

A M Cummings, J J Brown, R Fraser, A F Lever, J J Morton, D A Richards, J I Robertson.   

Abstract

1. Labetalol was given by incremental intravenous infusion to nineteen severely hypertensive patients, of whom nine were refractory to previous oral antihypertensive therapy. 2. Smooth reduction of arterial pressure was achieved in twelve subjects; one remained resistant to labetalol up to 160 mg/h; a sudden fall in pressure occurred in the remaining six. No serious complications were encountered. Blood pressure control was accompanied by slight byt significant reduction in heart rate and in plasma angiotensin II and aldosterone concentrations. 3. The administration of labetalol in this way appears to be a useful technique in patients requiring rapid reduction of arterial pressure, although close and continuous supervision is necessary.

Entities:  

Mesh:

Substances:

Year:  1979        PMID: 508511      PMCID: PMC1429845          DOI: 10.1111/j.1365-2125.1979.tb04719.x

Source DB:  PubMed          Journal:  Br J Clin Pharmacol        ISSN: 0306-5251            Impact factor:   4.335


  19 in total

1.  Hemodynamic effects of guanethidine in man.

Authors:  J N COHN; T E LIPTAK; E D FREIS
Journal:  Circ Res       Date:  1963-03       Impact factor: 17.367

2.  Clinical and chemical studies with alpha-methyl-dopa in patients with hypertension.

Authors:  L GILLESPIE; J A OATES; J R CROUT; A SJOERDSMA
Journal:  Circulation       Date:  1962-02       Impact factor: 29.690

Review 3.  Labetalol: a review of its pharmacology and therapeutic use in hypertension.

Authors:  R N Brogden; R C Heel; T M Speight; G S Avery
Journal:  Drugs       Date:  1978-04       Impact factor: 9.546

4.  Labetalol in hypertension.

Authors: 
Journal:  Lancet       Date:  1977-05-28       Impact factor: 79.321

5.  The renin response to diuretic therapyl A limitation of antihypertensive potential.

Authors:  E D Vaughan; R M Carey; M J Peach; J A Ackerly; C R Ayers
Journal:  Circ Res       Date:  1978-03       Impact factor: 17.367

6.  Prazosin in severe in hypertension effect on blood pressure, plasma renin activity and in hypertensive emergencies.

Authors:  J M Hayes
Journal:  Med J Aust       Date:  1977-08-27       Impact factor: 7.738

7.  Haemodynamic effects of combined alpha- and beta-adrenoreceptor blockade after intravenous labetalol in hypertensive patients at rest and during exercise.

Authors:  G Koch
Journal:  Br J Clin Pharmacol       Date:  1976-08       Impact factor: 4.335

8.  Effect of blood pressure angiotensin II and aldosterone concentrations during treatment of severe hypertension with intravenous labetalol: comparison with propranolol.

Authors:  P M Trust; E A Rosei; J J Brown; R Fraser; A F Lever; J J Morton; J I Robertson
Journal:  Br J Clin Pharmacol       Date:  1976-08       Impact factor: 4.335

9.  Management of complicated hypertension including hypertensive emergencies.

Authors:  D W Richardson; A J Raper
Journal:  Cardiovasc Clin       Date:  1978

10.  Acute haemodynamic effects of labetalol and its subsequent use of an oral hypotensive agent.

Authors:  A M Joekes; F D Thompson
Journal:  Br J Clin Pharmacol       Date:  1976-08       Impact factor: 4.335

View more
  3 in total

Review 1.  The management of hypertension.

Authors:  B N Prichard; C W Owens
Journal:  Br J Clin Pharmacol       Date:  1986       Impact factor: 4.335

2.  Intravenous labetalol in the treatment of severe hypertension.

Authors:  A M Cumming; J J Brown; A F Lever; J I Robertson
Journal:  Br J Clin Pharmacol       Date:  1982-06       Impact factor: 4.335

Review 3.  Combined alpha- and beta-receptor inhibition in the treatment of hypertension.

Authors:  B N Prichard
Journal:  Drugs       Date:  1984       Impact factor: 9.546

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.